CNETS Financial Support
CNETS
This page discusses Telotristat ethyl, a medication for refractory carcinoid syndrome diarrhea, and notes it is not funded in Canada. While CNETS offers patient assistance and financial support programs, the details regarding what these grants cover, who qualifies, or how to apply are not present on this specific page.
- Covers
- caregiver supporttransportationfinancial assistance
- Enrollment cycle
- unknown
Eligibility
The provided text details a schedule of support group meetings for neuroendocrine tumor patients and caregivers across Canada. It does not contain information regarding a travel grant or specific financial eligibility requirements.
Apply
Application goes directly to CNETS. RxCopays does not receive compensation.
Go to application →Status source
TELOTRISTAT ETIPRATE THERAPY Telotristat ethyl is indicated for the treatment of refractory carcinoid syndrome